Ocata Therapeutics Inc Stock OTC Bulletin Board

Stocks

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

16-02-10	Ocata Therapeutics : Astellas Announces Results of Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and Changes to Subsidiaries	PR
16-01-22	Ocata Therapeutics : Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics	PR
15-12-28	Ocata Therapeutics : Reports the Publication of Data about the Generation of Corneal Endothelial Cells from Human Pluripotent Stem Cells	BU
15-12-03	Ocata Therapeutics : Hemangio-derived Mesenchymal Cells Preserve Kidney Function and Extend Lifespan in Preclinical Model of Lupus Nephritis	BU
15-11-24	Ocata Therapeutics : Harwood Feffer LLP : Announces Investigation of Ocata Therapeutics, Inc.	PR

Manager	Title	Age	Since
John Heffernan PRN	Corporate Officer/Principal	-	2015-02-02

Director	Title	Age	Since
Toru Yoshimitsu BRD	Director/Board Member	63	-
Masaaki Hirano BRD	Director/Board Member	59	-
Percival Barretto-Ko BRD	Director/Board Member	53	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	+0.05%	+3.08%	+38.17%	+66.77%	56.54B
ARGENX SE	-3.06%	-8.56%	+23.62%	+58.73%	53.6B
BIONTECH SE	+1.84%	+1.27%	-14.06%	-13.50%	22.91B
INSMED INCORPORATED	-0.15%	-6.00%	-9.42%	+344.47%	21.37B
GENMAB A/S	-0.67%	-3.25%	+33.09%	-29.84%	17.56B
PHARMAESSENTIA CORPORATION	+9.91%	-2.51%	+188.84%	+326.19%	13.53B
EXELIXIS, INC.	+3.83%	-1.34%	+47.77%	+165.22%	13.33B
ARROWHEAD PHARMACEUTICALS, INC.	+1.61%	+0.56%	+439.92%	+166.12%	11.92B
MADRIGAL PHARMACEUTICALS, INC.	+3.14%	-12.56%	+59.51%	+149.39%	10.8B
Average	+1.83%	-2.26%	+89.72%	+137.06%	24.62B
Weighted average by Cap.	+0.47%	-1.93%	+56.70%	+106.80%